Evidence map›Paper›PMID 36970027›Full record

ArticleMethodsX2023

The influence of microinjection parameters on cell survival and procedure efficiency.

Joanna Hajduk, Konrad Szajna, Bartosz Lisowski, Zenon Rajfur

Open access · goldFull text read
In one paragraph

Article in MethodsX, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Joanna HajdukDoctoral School of Exact and Natural Sciences, Jagiellonian University, Łojasiewicza 11, Krakow 30-348, Poland.
Konrad SzajnaFaculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, Łojasiewicza 11, Krakow 30-348, Poland.
Bartosz LisowskiFaculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, Kraków 30-688, Poland.
Zenon RajfurFaculty of Physics, Astronomy and Applied Computer Science, Jagiellonian University, Łojasiewicza 11, Krakow 30-348, Poland.
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microinjection is a method commonly used to deliver various substances into cells. The procedure is performed on a widefield microscope stage using fine glass needle to penetrate the cell membrane. Microinjection can be carried out using a manual or semi-automatic mode. For commercially available equipment currently reported microinjection success rate and cell viability are relatively low (around 50% for both indicators). Here, for the first time, we systematically show how the microinjection effectiveness and cell viability are influenced by needle diameter and chosen microinjection mode. We found that manual mode entailed a higher injection rate, reducing cell viability at the same time. The reduction in needle diameter caused a significant increase in cell survival rate (from 43 to 73% for manual mode and from 58% to 86% for semi-automatic mode) and did not affect significantly the success rate. Our findings will help optimize this method in the context of cell biology research.•This study shows how to improve microinjection parameters, such as procedure efficiency and cell survival rate, for commercially available equipment.•Manual mode, in comparison with semi-automatic mode, results in higher microinjection efficiency, but lower cell survival rate.•The increase in micropipette diameter causes lower cell viability and a higher microinjection success rate.

Indexed as

Adherent cells manual and semi-automatic microinjectionCell cultureFibroblastsManualMicroinjectionSemi-automatic

Identifiers

PMID36970027
PMCPMC10034491
OpenAlexW4323322340

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read3
measurements read39
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.